Craigen W J, Jakobs C, Sekul E A, Levy M L, Gibson K M, Butler I J, Herman G E
Institute for Molecular Genetics, Baylor College of Medicine, Houston, Texas 77030.
Pediatr Neurol. 1994 Feb;10(1):49-53. doi: 10.1016/0887-8994(94)90067-1.
D-2-Hydroxyglutaric aciduria was documented in a newborn who presented with seizures, hypotonia, cortical blindness, a movement disorder, and developmental delay. Her clinical presentation differs from that of patients with L-2-hydroxyglutaric aciduria and a single previously reported patient with D-2-hydroxyglutaric aciduria. Cerebrospinal fluid levels of gamma-aminobutyric acid were elevated, while biogenic amine metabolites were normal. The movement disorder in our patient and in those with L-2-hydroxyglutaric aciduria suggests involvement of the basal ganglia in the disease process. Prenatal diagnosis of an affected fetus was accomplished during a subsequent pregnancy.
一名出现癫痫发作、肌张力减退、皮质盲、运动障碍和发育迟缓的新生儿被诊断为D-2-羟基戊二酸尿症。她的临床表现与L-2-羟基戊二酸尿症患者以及之前报道的一例D-2-羟基戊二酸尿症患者不同。脑脊液中γ-氨基丁酸水平升高,而生物胺代谢产物正常。我们的患者以及L-2-羟基戊二酸尿症患者的运动障碍提示基底神经节参与了疾病过程。在随后的一次妊娠中对一名受影响的胎儿进行了产前诊断。